Catalyst Wire Dossier Catalyst Wire Dossier

Phlogenzym

· Mucos Pharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Phlogenzym, covering 2018-03-19 to 2018-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance [Phase 3]

See pricing